$ACVA Cashflow Statement | Understand Stock

$ACVA

$10.50 +$0.00 (0.0%) Pre-market

$ACVA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows from Operating Activities
Net loss
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization
Stock-based compensation expense, net of amounts capitalized
Provision for bad debt
(Gain) on contingent liabilities
Other non-cash, net

Changes in operating assets and liabilities, net of effects from purchases of businesses:
Trade receivables
Other operating assets
Accrued interest on marketable securities
Accounts payable
Accrued payroll
Accrued other liabilities
Deferred revenue
Other operating liabilities
Other assets

Net cash provided by (used in) operating activities
Cash Flows from Investing Activities
Net increase in finance receivables
Purchases of property and equipment
Proceeds from sale of real estate
Capitalization of software costs
Purchases of marketable securities
Maturities and redemptions of marketable securities
Sales of marketable securities
Acquisition of businesses (net of cash acquired)
Net cash used in investing activities
Cash Flows from Financing Activities
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and other offering costs
Proceeds from long term debt
Proceeds from issuance of Series E1 preferred stock
Payments towards promissory note
Payments towards long term debt
Proceeds from exercise of stock options
Payments for debt issuance and other financing costs
Payment of RSU tax withholdings in exchange for common shares surrendered by RSU holders
Proceeds from employee stock purchase plan
Other financing activities
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash, cash equivalents, and restricted cash
Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash, beginning of period
Cash, cash equivalents, and restricted cash, end of period
Supplemental disclosure of cash flow information
Cash paid during the period for:
Interest expense
Income taxes
Cash paid included in the measurement of operating lease liabilities

Non-cash investing and financing activities:
Right-of-use assets obtained, including initial adoption
Contingent consideration
Stock-based compensation included in capitalized software development costs
Noncash or Part Noncash Acquisition, Fixed Assets Acquired
Purchase of property and equipment and internal use software in accounts payable

Comments